Research News and Research

RSS
Psychogenics Picks Up Alzheimer’s Animal Model From USF

Psychogenics Picks Up Alzheimer’s Animal Model From USF

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

First Edition: August 22, 2013

First Edition: August 22, 2013

Ireland’s Health Research Board awards €1.2M to UL researchers

Ireland’s Health Research Board awards €1.2M to UL researchers

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

Drug oxytocin may contribute to postpartum bleeding, researchers find

Drug oxytocin may contribute to postpartum bleeding, researchers find

Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

Use of psychotherapy on a clear decline in US

Use of psychotherapy on a clear decline in US

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

Journal of Spinal Cord Medicine's July issue focuses on assistive technology for spinal cord injury

New focus on long-term effects of Fukushima Daiichi nuclear disaster

New focus on long-term effects of Fukushima Daiichi nuclear disaster

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Antipsychotic drug not effective in treating delirium in critically ill patients

Antipsychotic drug not effective in treating delirium in critically ill patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.